Wojciech Majewski
Papers
1
Total Citations
7
H-Index
1
About
Dr. Wojciech Majewski is a leading clinical researcher in radiation oncology, with a focused expertise in stereotactic body radiotherapy (SBRT) for prostate cancer. His most cited work, a 2015 prospective study on the acute toxicity of robotic ultrahypofractionated radiotherapy using the CyberKnife™ system, represents a foundational contribution to the field. This landmark paper, cited 7 times, provided critical safety data by demonstrating that a total dose of 36.25 Gy delivered in just five fractions is well-tolerated in low- and intermediate-risk patients. By meticulously documenting the acute toxicity profile in 132 men, Dr. Majewski’s research helped validate the clinical feasibility of extreme hypofractionation, paving the way for shorter, more convenient treatment regimens. His work directly addresses the critical balance between maximizing tumor control and minimizing side effects, making him a key figure in the advancement of non-invasive prostate cancer therapies. Dr. Majewski’s contributions continue to inform modern radiotherapy protocols and improve patient quality of life.
Research Focus
Key Achievements
Top Papers
- 1